Medical Device & Diagnostics Terms and Definitions Monographs
Developed by the ISPOR Medical Devices & Diagnostics Special Interest Group
-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Global Access to Medical Innovation
- Health Equity Research
- Health Preference Research
- Medical Devices and Diagnostics
- Medication Adherence and Persistence
- Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Patient Reported Outcomes (PROs) in Prospective Real World Study Design
- Performance Outcome (PerfO) Assessments
- Structured Expert Elicitation for Healthcare Decision Making
- Surrogate Endpoint Statistical Evaluation for HTA Decision Making
- Use of Electronic Health Records for Health Technology Assessment
- Valuing HRQoL of Children & Adolescents in Economic Evaluation (Pediatric Utilities)
- Value-Based Healthcare Implementation Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
- Online Communities
Authors:
Michael Cangelosi, MA, MPH, Associate Director, Health Economics, Boston Scientific, Marlborough, MA, USA
Akriti Chahar, PhD, Consultant, IQVIA, New Delhi, India
Vanessa Danielson, MSc, Vice President, Global Pricing, Health Economics, Market Access and Reimbursement, LivaNova, Nottingham, England, UK
Melodi Koşaner Kließ, MRes, MSc, Health Economist, Duisburg, Germany
Manpreet Sidhu, PhD, MBA, Executive Director, Global Health Economics, Outcomes Research and Epidemiology, Ultragenyx, New York, NY, USA
Mriga Shrikhande, MS, student, University of Arkansas for Medical Sciences, Little Rock, AR
Many thanks to the MDD SIG members that reviewed the draft monographs. Your expertise and insight improved these monographs and contributed to their consensus nature.